Login to Your Account



Adaptive pathways program to continue after EMA's 2-year pilot

By Nuala Moran
Staff Writer

Thursday, August 4, 2016

LONDON – It's so far, so good for adaptive pathways, with the EMA's final report on its pilot scheme concluding that staggered approval from a small patient subgroup to an increasingly wide patient population can support development in indications where it is hard to generate sufficient data.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription